Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A4I198
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0016791 | phosphatase activity | 5 | 1 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 126 | 130 | PF00656 | 0.742 |
CLV_C14_Caspase3-7 | 308 | 312 | PF00656 | 0.546 |
CLV_NRD_NRD_1 | 285 | 287 | PF00675 | 0.336 |
CLV_NRD_NRD_1 | 301 | 303 | PF00675 | 0.222 |
CLV_NRD_NRD_1 | 332 | 334 | PF00675 | 0.517 |
CLV_PCSK_KEX2_1 | 301 | 303 | PF00082 | 0.307 |
CLV_PCSK_KEX2_1 | 332 | 334 | PF00082 | 0.517 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.526 |
DEG_SPOP_SBC_1 | 173 | 177 | PF00917 | 0.710 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 288 | 297 | PF00134 | 0.546 |
DOC_USP7_MATH_1 | 123 | 127 | PF00917 | 0.751 |
DOC_USP7_MATH_1 | 182 | 186 | PF00917 | 0.689 |
DOC_USP7_MATH_1 | 233 | 237 | PF00917 | 0.767 |
DOC_USP7_MATH_1 | 62 | 66 | PF00917 | 0.541 |
DOC_USP7_MATH_1 | 97 | 101 | PF00917 | 0.705 |
DOC_WW_Pin1_4 | 202 | 207 | PF00397 | 0.672 |
LIG_14-3-3_CanoR_1 | 163 | 173 | PF00244 | 0.693 |
LIG_14-3-3_CanoR_1 | 198 | 207 | PF00244 | 0.615 |
LIG_APCC_ABBA_1 | 316 | 321 | PF00400 | 0.546 |
LIG_BRCT_BRCA1_1 | 200 | 204 | PF00533 | 0.623 |
LIG_BRCT_BRCA1_1 | 226 | 230 | PF00533 | 0.730 |
LIG_Clathr_ClatBox_1 | 323 | 327 | PF01394 | 0.546 |
LIG_FHA_1 | 34 | 40 | PF00498 | 0.439 |
LIG_FHA_2 | 244 | 250 | PF00498 | 0.546 |
LIG_FHA_2 | 82 | 88 | PF00498 | 0.717 |
LIG_GBD_Chelix_1 | 251 | 259 | PF00786 | 0.346 |
LIG_Integrin_isoDGR_2 | 330 | 332 | PF01839 | 0.436 |
LIG_LIR_Gen_1 | 313 | 323 | PF02991 | 0.546 |
LIG_LIR_Nem_3 | 201 | 207 | PF02991 | 0.651 |
LIG_LIR_Nem_3 | 261 | 267 | PF02991 | 0.526 |
LIG_LIR_Nem_3 | 298 | 303 | PF02991 | 0.543 |
LIG_LIR_Nem_3 | 313 | 318 | PF02991 | 0.460 |
LIG_LIR_Nem_3 | 58 | 63 | PF02991 | 0.575 |
LIG_LYPXL_yS_3 | 265 | 268 | PF13949 | 0.546 |
LIG_NRBOX | 255 | 261 | PF00104 | 0.546 |
LIG_PDZ_Class_2 | 335 | 340 | PF00595 | 0.579 |
LIG_Pex14_2 | 315 | 319 | PF04695 | 0.504 |
LIG_SH2_CRK | 26 | 30 | PF00017 | 0.467 |
LIG_SH2_CRK | 80 | 84 | PF00017 | 0.780 |
LIG_SH2_NCK_1 | 80 | 84 | PF00017 | 0.702 |
LIG_SH2_STAT5 | 10 | 13 | PF00017 | 0.498 |
LIG_SH2_STAT5 | 214 | 217 | PF00017 | 0.628 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.779 |
LIG_SH3_3 | 204 | 210 | PF00018 | 0.653 |
LIG_SUMO_SIM_par_1 | 265 | 270 | PF11976 | 0.546 |
LIG_SUMO_SIM_par_1 | 292 | 299 | PF11976 | 0.546 |
LIG_SUMO_SIM_par_1 | 320 | 327 | PF11976 | 0.619 |
LIG_TRAF2_1 | 113 | 116 | PF00917 | 0.628 |
MOD_CK1_1 | 176 | 182 | PF00069 | 0.808 |
MOD_CK1_1 | 202 | 208 | PF00069 | 0.695 |
MOD_CK1_1 | 55 | 61 | PF00069 | 0.576 |
MOD_CK2_1 | 141 | 147 | PF00069 | 0.737 |
MOD_CK2_1 | 243 | 249 | PF00069 | 0.532 |
MOD_CK2_1 | 292 | 298 | PF00069 | 0.546 |
MOD_CK2_1 | 6 | 12 | PF00069 | 0.362 |
MOD_Cter_Amidation | 330 | 333 | PF01082 | 0.551 |
MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.702 |
MOD_GlcNHglycan | 226 | 229 | PF01048 | 0.804 |
MOD_GlcNHglycan | 277 | 280 | PF01048 | 0.313 |
MOD_GlcNHglycan | 54 | 57 | PF01048 | 0.495 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.698 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.803 |
MOD_GSK3_1 | 164 | 171 | PF00069 | 0.801 |
MOD_GSK3_1 | 172 | 179 | PF00069 | 0.712 |
MOD_GSK3_1 | 198 | 205 | PF00069 | 0.657 |
MOD_GSK3_1 | 322 | 329 | PF00069 | 0.690 |
MOD_GSK3_1 | 62 | 69 | PF00069 | 0.579 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.740 |
MOD_N-GLC_1 | 105 | 110 | PF02516 | 0.714 |
MOD_N-GLC_1 | 141 | 146 | PF02516 | 0.761 |
MOD_N-GLC_1 | 199 | 204 | PF02516 | 0.712 |
MOD_N-GLC_1 | 305 | 310 | PF02516 | 0.346 |
MOD_N-GLC_1 | 6 | 11 | PF02516 | 0.360 |
MOD_NEK2_1 | 267 | 272 | PF00069 | 0.524 |
MOD_NEK2_1 | 28 | 33 | PF00069 | 0.471 |
MOD_NEK2_1 | 326 | 331 | PF00069 | 0.429 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.482 |
MOD_PIKK_1 | 141 | 147 | PF00454 | 0.698 |
MOD_PIKK_1 | 64 | 70 | PF00454 | 0.644 |
MOD_PKA_1 | 332 | 338 | PF00069 | 0.514 |
MOD_PKA_2 | 332 | 338 | PF00069 | 0.514 |
MOD_Plk_1 | 141 | 147 | PF00069 | 0.725 |
MOD_Plk_1 | 6 | 12 | PF00069 | 0.362 |
MOD_Plk_2-3 | 322 | 328 | PF00069 | 0.619 |
MOD_Plk_4 | 251 | 257 | PF00069 | 0.546 |
MOD_Plk_4 | 292 | 298 | PF00069 | 0.546 |
MOD_Plk_4 | 332 | 338 | PF00069 | 0.514 |
MOD_Plk_4 | 55 | 61 | PF00069 | 0.528 |
MOD_Plk_4 | 78 | 84 | PF00069 | 0.699 |
MOD_ProDKin_1 | 202 | 208 | PF00069 | 0.667 |
MOD_SUMO_for_1 | 113 | 116 | PF00179 | 0.725 |
MOD_SUMO_rev_2 | 236 | 241 | PF00179 | 0.760 |
TRG_DiLeu_BaEn_4 | 321 | 327 | PF01217 | 0.546 |
TRG_DiLeu_BaLyEn_6 | 263 | 268 | PF01217 | 0.546 |
TRG_ENDOCYTIC_2 | 26 | 29 | PF00928 | 0.458 |
TRG_ENDOCYTIC_2 | 264 | 267 | PF00928 | 0.526 |
TRG_ENDOCYTIC_2 | 300 | 303 | PF00928 | 0.546 |
TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.779 |
TRG_ER_diArg_1 | 300 | 302 | PF00400 | 0.546 |
TRG_ER_diArg_1 | 332 | 334 | PF00400 | 0.517 |
TRG_Pf-PMV_PEXEL_1 | 189 | 193 | PF00026 | 0.630 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKW7 | Leptomonas seymouri | 58% | 90% |
A0A3S7WYV2 | Leishmania donovani | 100% | 100% |
A4HEG1 | Leishmania braziliensis | 81% | 100% |
E9AXD4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 96% |
Q4QA38 | Leishmania major | 93% | 100% |